leisure time -WSS

leisure time

author：knowledge 2025-09-03 11:47:17 - browse：55

Slayman with (left to right) Dr. Leo Riella, Medical Director of Kidney Transplantation, Dr. Nahel Elias, Interim Chief, Division of Transplant Surgery, his partner, Faren, and Dr. Tatsuo Kawai, Director, Legorreta Center for Clinical Transplant Tolerance. -- HEALTH coverage from STAT — Rick Slayman, holding hands with his partner, Faren, poses with members of his Massachusetts General Hospital medical team before being going home last month. Michelle Rose/Massachusetts General Hospital

Rick Slayman, the first man to receive a kidney transplant from a genetically engineered pig, has died, according to a statement from his family and Massachusetts General Hospital, where he underwent the historic operation in March.

“Our family is deeply saddened about the sudden passing of our beloved Rick but take great comfort knowing he inspired so many,” his family said in the statement released Saturday evening.

The hospital did not say how or when Slayman died. A spokesperson declined to provide further information, citing “privacy issues.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： CDC's new outbreak response network to include Northeastern

focus

WSS

Fatty liver disease was alleviated by Lilly’s ‘triple

CommonSpirit Health keeps growing, even as it loses money

The wait for US passports is creating travel purgatory and snarling summer plans

Drug cartel violence flares in western Mexico after vigilante leader's killing

Second xenotransplant done with gene

Skip the lead apron during X

explore

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Continuity nursing helped my family in our darkest PICU moments

Canadians with cystic fibrosis outlive Americans by a decade

The high cost of giving birth even with insurance

Readout LOUD podcast: possible new ALS drug, artificial wombs

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What affirmative action's end means to a medical student

Novavax promises a turnaround & Lilly roils the obesity market

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Bright Health sells Medicare Advantage business to Molina

Lasker Awards 2023: Winners in biomedical research

entertainment

How Vertex's cystic fibrosis drug is changing patients' lives

Intarcia’s device

Canadians with cystic fibrosis outlive Americans by a decade

STAT wants to know your pick for a great summer read or listen

Experts study whether long Covid risk adds up with each reinfection

Senators: Long

entertainment

focus

focus

leisure time